Samuel Whiting serves as Executive at Millendo Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Samuel Whiting has executed 3 insider transactions totaling $18.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 2, 2024 involved purchasing 4,672 shares valued at $10.0K.
Samuel Whiting currently holds 9,573 shares of Millendo Therapeutics, Inc. (TPST), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Samuel Whiting has been a net buyer of TPST stock. They have purchased $18.1K and sold $0 worth of shares.
Samuel Whiting's most recent insider trade was on Jul 2, 2024, when they purchased 4,672 shares at $2.13 per share.
Get notified when new Form 4 filings are submitted
| $4.80 |
| Discretionary |
| Jun 25, 2021 | TPST | $0 | Award | 201 | $N/A | Discretionary |